Navana Pharmaceuticals PLC
Navana Pharmaceuticals PLC, a prominent player in the pharmaceutical industry, is headquartered in Bangladesh (BD) and has established a significant presence across various operational regions. Founded in 1992, the company has achieved notable milestones, including the development of a diverse portfolio of high-quality generic and branded medications. Specialising in therapeutic areas such as cardiology, diabetes, and infectious diseases, Navana Pharmaceuticals is recognised for its commitment to innovation and quality. Their core products, which include a range of formulations and dosage forms, are distinguished by rigorous adherence to international standards and regulatory compliance. With a strong market position, Navana Pharmaceuticals has garnered accolades for its contributions to healthcare, making it a trusted name in the industry. The company continues to expand its reach, aiming to enhance patient care both locally and globally.
DitchCarbon Score
How does Navana Pharmaceuticals PLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Navana Pharmaceuticals PLC's score of 20 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Navana Pharmaceuticals PLC's reported carbon emissions
Navana Pharmaceuticals PLC, headquartered in Bangladesh (BD), currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not disclosed. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or commitments to the Science Based Targets initiative (SBTi) or similar climate pledges. This lack of information suggests that Navana Pharmaceuticals may still be in the early stages of formalising its climate strategy and emissions reduction initiatives. As the pharmaceutical industry increasingly prioritises sustainability, it is crucial for companies like Navana Pharmaceuticals to establish clear climate commitments and transparent reporting practices to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Navana Pharmaceuticals PLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
